期刊文献+

克罗恩病的循证治疗 被引量:1

Evidence-Based Treatment for Crohn's Disease
下载PDF
导出
摘要 目的针对1例常规治疗疗效不理想的克罗恩病患者,我们进行了证据检索和评价,以期找到更有效的治疗方法。方法计算机检索MEDLINE(1978-2006年)和Cochrane图书馆(2007年第4期)等,查找治疗克罗恩病及与病情缓解有关的系统评价、临床随机对照试验等,并对所获证据进行评价。结果纳入克罗恩病治疗的随机对照试验11篇,系统评价或Meta分析8篇,根据所获证据给患者制定治疗方案。结论以高质量证据、结合患者情况制定治疗方案,能明显提高克罗恩病患者的近期疗效,但远期预后尚需更长时间的随访观察。 Objective To find the most effective treatment for patients with Crohn's disease whose therapeutic effect was not ideal by EBM practice. Methods We attempted to get the evidence of method which was used to treat Crohn's disease and maintain remission by searching MEDLINE (1978-2006) and The Cochrane Library (Issue 4, 2007) and the critical appraised evidence. Results A total of 11 randomized controlled trials, 8 systematic reviews and meta-analyses were identified. The treatment plan was developed accordingly. Conclusions The individualized treatment plan based on the high quality evidence and patient's condition is optimal for the short-term treatment of Crohn's disease. However, the long-term prognostic benefits need to be confirmed by continuing follow-up.
出处 《循证医学》 CSCD 2008年第3期143-146,152,共5页 The Journal of Evidence-Based Medicine
关键词 克罗恩病 5-氨基水杨酸 糖皮质激素 免疫抑制剂 循证治疗 Crohn's disease 5-aminosalicyclic acid corticosteroids immunomodulator drugs evidence-based treatment
  • 相关文献

参考文献19

  • 1Hanauer SB, Stromberg U. Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials [J]. Clin Gastroenterol Hepatol, 2004, 2(5) :379-388.
  • 2Gisbert JP, Gomollon F, Pajares JM. Role of 5-aminoalicyclic acid (5-ASA) in the treatment of inflammatory bowd disease: A systematic review [J]. Digestive Disease and Science, 2002, 47(3) :471-488.
  • 3Steinhart All, Ewe K, Griffiths AM, et al. Corticosteroids for maintenance of remission in Crohn's disease [DB/CD]. Cochrane Database of Systematic Reviews, Issue 4,2007.
  • 4Tremaine WJ, Hanauer SB, Katz S, et al. Budesonide CIR capsules in active Crohn's disease: A randomized placebocontrolled study in the United States [J]. Am J Gastroenterol, 2002,97 : 1745-1754.
  • 5Simms L, Steinhart All. Budesonide for maintenance of remission in Crohn's disease [DB/CD]. Cochrane Database of Systematic Reviews, Issue 4, 2007.
  • 6Sandborn W,Sutherland L, Pearson D, et al. Azathioprine or 6-mercaptopurine for inductionof remission in Crohn's disease[DB/CD]. Cochrane Database of Systematic Reviews, Issue 4, 2007.
  • 7Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: A 30 year review [J]. Gut, 2002,50:485-489.
  • 8Alfadhli AAF, Mcdonald JWD, Feagan BG. Methotrexate for induction of remission in refractory Crohn's disease [DB/CD]. Cochrane Database of Systematic Reviews, Issue 4, 2007.
  • 9Lichtenstein GR, AbrenMT, Coher R, et al. American gastmenterological association institute technical review on corticosteroids,immunomodulators,and infliximabin inflammatory bowel disease [J]. Gastroenterology, 2006, 130(3) :940-987.
  • 10McDonald JWD, Feagan BG Jewell D, et al. Cyclosporine for induction of remission in Crohn's disease [DB/CD]. Cochrane Database of Systematic Reviews, Issue 4, 2007.

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部